WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009061881) SPIRODIHYDROBENZOFURANS AS MODULATORS OF CHEMOKINE RECEPTORS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/061881    International Application No.:    PCT/US2008/082579
Publication Date: 14.05.2009 International Filing Date: 06.11.2008
IPC:
A01N 43/40 (2006.01), A61K 31/44 (2006.01)
Applicants: GLAXO GROUP LIMITED [GB/GB]; Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex UB6 0NN (GB) (For All Designated States Except US).
BUDZIK, Brian, W. [US/US]; (US) (For US Only).
HAILE, Pamela, A. [US/US]; (US) (For US Only).
HUGHES, Terry, Vincent [US/US]; (US) (For US Only).
SEHON, Clark, A. [US/US]; (US) (For US Only).
WANG, Gren, Z. [US/US]; (US) (For US Only)
Inventors: BUDZIK, Brian, W.; (US).
HAILE, Pamela, A.; (US).
HUGHES, Terry, Vincent; (US).
SEHON, Clark, A.; (US).
WANG, Gren, Z.; (US)
Agent: WILLIS, Reid, S.; Glaxosmithkline, Corporate Intellectual Property, UW2220, 709 Swedeland Road, P.O. Box 1539, King Of Prussia, PA 19406-0939 (US)
Priority Data:
60/986,049 07.11.2007 US
61/090,244 20.08.2008 US
Title (EN) SPIRODIHYDROBENZOFURANS AS MODULATORS OF CHEMOKINE RECEPTORS
(FR) COMPOSÉS DE SPIRODIHYDROBENZOFURANE COMME MODULATEURS DE RÉCEPTEURS DES CHIMIOKINES
Abstract: front page image
(EN)The present invention relates to a compound of the following formula: or a pharmaceutically acceptable salt thereof, wherein R1 -R4, R8, R9, Y, m, n, and p are defined. Compounds and compositions of the present invention are useful, for example, for the treatment of atherosclerosis.
(FR)L'invention concerne un composé représenté par la formule suivante: ou un sel pharmaceutiquement acceptable de ce composé. Dans la formule, R1 -R4, R8, R9, Y, m, n et p sont définis. Les composés et compositions de l'invention sont utiles, par exemple, dans le traitement de l'athérosclérose.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)